Traitement percutané de l’insuffisance mitrale par Mitraclip chez le sujet âgé

Nkomo, 2006, Burden of valvular heart diseases: a population-based study, Lancet, 368, 1005, 10.1016/S0140-6736(06)69208-8 Iung, 2003, A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease, Eur Heart J, 24, 1231, 10.1016/S0195-668X(03)00201-X Mirabel, 2007, What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?, Eur Heart J, 28, 1358, 10.1093/eurheartj/ehm001 Joint Task Force on the Management of Valvular Heart Disease of the European Society of C, 2012, Guidelines on the management of valvular heart disease (version 2012), Eur Heart J, 33, 2451, 10.1093/eurheartj/ehs109 Baumgartner, 2017, 2017 ESC/EACTS Guidelines for the management of valvular heart disease, Eur Heart J, 38, 2739, 10.1093/eurheartj/ehx391 Carpentier, 1983, Cardiac valve surgery--the “French correction”, J Thorac Cardiovasc Surg, 86, 323, 10.1016/S0022-5223(19)39144-5 Singh, 1999, Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study), Am J Cardiol, 83, 897, 10.1016/S0002-9149(98)01064-9 Enriquez-Sarano, 2009, Mitral regurgitation, Lancet, 373, 1382, 10.1016/S0140-6736(09)60692-9 Alegria-Barrero, 2012, Edge-to-edge percutaneous repair of severe mitral regurgitation--state-of-the-art for Mitraclip(R) implantation, Circ J, 76, 801, 10.1253/circj.CJ-11-1462 Guerin, 2016, MitraClip therapy in mitral regurgitation: a Markov model for the cost-effectiveness of a new therapeutic option, J Med Econ, 19, 696, 10.3111/13696998.2016.1157484 Vahanian, 2012, Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), Eur J Cardio-Thoracic Surg, 42, S1, 10.1093/ejcts/ezs455 Haan, 2004, Selecting patients with mitral regurgitation and left ventricular dysfunction for isolated mitral valve surgery, Ann Thoracic Surg, 78, 820, 10.1016/j.athoracsur.2004.04.003 Enriquez-Sarano, 1994, Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications, J Am Coll Cardiol, 24, 1536, 10.1016/0735-1097(94)90151-1 Enriquez-Sarano, 2005, Quantitative determinants of the outcome of asymptomatic mitral regurgitation, N Engl J Med, 352, 875, 10.1056/NEJMoa041451 Barbieri, 2011, Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a multicenter long-term international study, Eur Heart J, 32, 751, 10.1093/eurheartj/ehq294 Tribouilloy, 2009, Survival implication of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets a long-term follow-up multicenter study, J Am Coll Cardiol, 54, 1961, 10.1016/j.jacc.2009.06.047 Le Tourneau, 2010, Impact of left atrial volume on clinical outcome in organic mitral regurgitation, J Am Coll Cardiol, 56, 570, 10.1016/j.jacc.2010.02.059 Olson, 1987, Surgical pathology of the mitral valve: a study of 712 cases spanning 21 years, Mayo Clin Proc, 62, 22, 10.1016/S0025-6196(12)61522-5 Nishimura, 2016, Mitral valve disease--current management and future challenges, Lancet, 387, 1324, 10.1016/S0140-6736(16)00558-4 Nishimura, 2014, 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 63, e57, 10.1016/j.jacc.2014.02.536 Ling, 1996, Clinical outcome of mitral regurgitation due to flail leaflet, N Engl J Med, 335, 1417, 10.1056/NEJM199611073351902 Grigioni, 1999, Sudden death in mitral regurgitation due to flail leaflet, J Am Coll Cardiol, 34, 2078, 10.1016/S0735-1097(99)00474-X Young, 2014, Percutaneous mitral valve repair, Curr Cardiol Rep, 16, 443, 10.1007/s11886-013-0443-6 Charlson, 1987, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chronic Dis, 40, 373, 10.1016/0021-9681(87)90171-8 Ponikowski, 2016, Eur Heart J, 37, 2129, 10.1093/eurheartj/ehw128 Obadia, 2018, Percutaneous repair or medical treatment for secondary mitral regurgitation, N Engl J Med, 10.1056/NEJMoa1805374 Stone, 2018, Transcatheter mitral-valve repair in patients with heart failure, N Engl J Med, 10.1056/NEJMoa1806640 Boekstegers, 2014, Percutaneous interventional mitral regurgitation treatment using the MitraClip system, Clin Res Cardiol, 103, 85, 10.1007/s00392-013-0614-x Feldman, 2011, Percutaneous repair or surgery for mitral regurgitation, N Engl J Med, 364, 1395, 10.1056/NEJMoa1009355 Feldman, 2015, Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II, J Am Coll Cardiol, 66, 2844, 10.1016/j.jacc.2015.10.018 Maisano, 2013, Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe, J Am Coll Cardiol, 62, 1052, 10.1016/j.jacc.2013.02.094 Obadia, 2015, The MITRA-FR study: design and rationale of a randomised study of percutaneous mitral valve repair compared with optimal medical management alone for severe secondary mitral regurgitation, EuroIntervention, 10, 1354, 10.4244/EIJV10I11A232 Stone, 2015, Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 1: clinical trial design principles: a consensus document from the mitral valve academic research consortium, Eur Heart J, 36, 1851, 10.1093/eurheartj/ehv281